IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.

Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L, Tian Y, Li H, Li J, Hu H, He J, Hu Y, Zhi C, Tang Z, Gong Y, Xu F, Xu L, Fan W, Zhao M, Chen D, Lian H, Yang L, Li P, Zhang Z. · 2021

Read IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. by Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L, Tian Y, Li H, Li J, Hu H, He J, Hu Y, Zhi C, Tang Z, Gong Y, Xu F, Xu L, Fan W, Zhao M, Chen D, Lian H, Yang L, Li P, Zhang Z. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8323212.txt.

Description

Pang and co-authors engineer CAR-T cells that secrete IL-7 and CCL19 for solid tumours. CAR-T therapy excels in blood cancers but fades in solid ones. Poor entry into tumours is a core fault.

The team built human CAR-T cells that release both signals. In dishes, the cells expanded and migrated better. They targeted glypican-3 or mesothelin on tumour cells. In mouse grafts of liver cancer, they beat standard CAR-T cells. Primary human tumour samples also responded. The added signals draw and sustain the attack. Solid tumour CAR design gains a tested upgrade.

Catalog record

CREATORPang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L, Tian Y, Li H, Li J, Hu H, He J, Hu Y, Zhi C, Tang Z, Gong Y, Xu F, Xu L, Fan W, Zhao M, Chen D, Lian H, Yang L, Li P, Zhang Z.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE13 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8323212

Browse the full library · About the Tower of Babel